comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 00:48:50 - browse：9149

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How AI can help patients find reliable information about doctors

WSS

Why a market frenzy over new weight loss drugs defies logic

Cherokee Nation medical school graduates its first class

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Obesity drug from Roche shows promise in early study

Cherokee Nation medical school graduates its first class

focus

comprehensive

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

J&J lung cancer data amount to new salvo against AstraZeneca

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study on Amgen’s bispecific immunotherapy produces positive data

What does generative AI mean for health care? We asked experts

As H5N1 spreads in cows, experts warn against drinking raw milk

United colonoscopy coverage change 'may cost lives,' doctors say

Study on Amgen’s bispecific immunotherapy produces positive data

Duchenne breakthrough therapy leaves behind pioneering families

HHS suspends federal funding for EcoHealth Alliance

leisure time

Cherokee Nation medical school graduates its first class

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

The United States must get value

Abbott's new stent may help patients with peripheral artery disease

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

knowledge

explore

knowledge

Wikipedia